Human Papillomavirus
(asked on 15th July 2014) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what assessment they have made of the care received by girls suffering from vaccine injury related to the human papilloma virus vaccine.
The Department has not made such an assessment. The Medicines and Healthcare products Regulatory Agency (MHRA), has closely evaluated the safety of Human papillomavirus (HPV) vaccine since introduction in the national immunisation programme in 2008. In September 2012 the MHRA sought advice from the Commission on Human Medicines (CHM) on the safety of HPV vaccine, which advised that no new safety concerns have been identified and the balance of risks and benefits of the vaccine remains positive.
The MHRA reviews are available on the MHRA website:
The MHRA continues to closely evaluate the safety of Gardasil HPV vaccine since it replaced Cervarix in 2012.